Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Righttothetopon Jun 11, 2021 1:26pm
136 Views
Post# 33373063

RE:RE:volume

RE:RE:volumeThere isn't any news worthy of putting out, or frankly important in any way, other than growth to either (and preferably both) top and bottom lines.

They spent years putting out NRs on agreements with timbuktoo and timbukthree and strategic arrangements with Stada etc.  It clearly mattered none.

So apart from the expected and hopefully upcoming CEO appointment (which itself is unlikely to make an impact unless they found a way to channel Steve Jobs or get Elon to work for a nickel), we really are stuck just waiting and hoping that the financials get better with every Q report from here on in.

Not a good place to be, but it is what it is.  I myself obviously come to this page to see if there is anything of note, but I really do need to train myself to not bother given that financial releases are all the are relevant.  (but I;ll still come anyway...lol)

corvette67 wrote: Unfortunately it is obvious more people want out  than in. If there is higher volume it will probably be negative, They need some real news as opposed to the fluff they normally out. GLTA


<< Previous
Bullboard Posts
Next >>